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The public health impact of Chikungunya virus (CHIKV) is often underestimated. Usually
considered a mild condition of short duration, recent outbreaks have reported greater inci-
dence of severe illness, fatality, and longer-term disability. In 2018/19, Eastern Sudan expe-
rienced the largest epidemic of CHIKV in Africa to date, affecting an estimated 487,600
people. Known locally as Kankasha, this study examines clinical characteristics, risk factors,
and phylogenetics of the epidemic in Kassala City.
Methodology/Principal findings
A prospective cohort of 102 adults and 40 children presenting with chikungunya-like illness
were enrolled at Kassala Teaching Hospital in October 2018. Clinical information, socio-
demographic data, and sera samples were analysed to confirm diagnosis, characterise ill-
ness, and identify viral strain. CHIKV infection was confirmed by real-time reverse transcrip-
tion-PCR in 84.5% (120/142) of participants. Nine (7.5%) CHIKV-positive participants had
concurrent Dengue virus (DENV) infection; 34/118 participants (28.8%) had a positive







Citation: Bower H, el Karsany M, Adam AAAH,
Idriss MI, Alzain MA, Alfakiyousif MEA, et al.
(2021) “Kankasha” in Kassala: A prospective
observational cohort study of the clinical
characteristics, epidemiology, genetic origin, and
chronic impact of the 2018 epidemic of
Chikungunya virus infection in Kassala, Sudan.
PLoS Negl Trop Dis 15(4): e0009387. https://doi.
org/10.1371/journal.pntd.0009387
Editor: Brett M. Forshey, DoD - AFHSB, UNITED
STATES
Received: September 23, 2020
Accepted: April 14, 2021
Published: April 30, 2021
Copyright: © 2021 Bower et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The authors confirm
that all data underlying the findings are available on
request from the LSHTM Data Compass
Repository DOI: https://doi.org/10.17037/DATA.
00002018. Study consent requires data be made
available for ethically-approved research only:
requests can be made here: https://datacompass.
lshtm.ac.uk/cgi/request_doc?docid=10142 or by
emailing researchdatamanagement@lshtm.ac.uk.
Rapid Diagnostic Test for Plasmodium falciparum; six (5.0%) had haemorrhagic symptoms
including two children with life-threatening bleeding. One CHIKV-positive participant died
with acute renal injury. Age was not associated with severity of illness although CHIKV-
infected participants were younger (p = 0.003).
Two to four months post-illness, 63% of adults available for follow-up (30) were still
experiencing arthralgia in one or more joints, and 11% remained moderately disabled on
Rapid3 assessment. Phylogenetic analysis showed all CHIKV sequences from this study
belonged to a single clade within the Indian Ocean Lineage (IOL) of the East/Central/South
African (ECSA) genotype. History of contact with an infected person was the only factor
associated with infection (p = 0.01), and likely related to being in the same vector
environment.
Conclusions/Significance
Vulnerability to CHIKV remains in Kassala and elsewhere in Sudan due to widespread
Aedes aegypti presence and mosquito-fostering household water storage methods. This
study highlights the importance of increasing awareness of the severity and impact of
CHIKV outbreaks, and the need for urgent actions to reduce transmission risk in
households.
Author summary
Chikungunya is an arboviral disease transmitted to humans by infected mosquitoes and
characterised by fever and arthralgia. Although it is generally considered a short self-limit-
ing infection, long term sequelae and severe disease are increasingly recognised. In 2018/
19, Eastern Sudan experienced the largest epidemic of Chikungunya in Africa to date,
affecting approximately 500,000 people. We undertook a prospective hospital-based
cohort study of patients presenting with undifferentiated febrile illness in Kassala city,
Sudan, supported by next-generation sequencing. We confirmed that CHIKV was the
dominant pathogen, with positive CHIKV RT-PCR in 85% of patients presenting during
the 7-day study period. Dengue virus was also circulating with nine CHIKV RT-PCR-pos-
itive patients co-infected, and we identified high rates of Plasmodium falciparum infection
and CHIKV/P.falciparum co-infection. Genetic sequencing confirmed Indian Ocean
Lineage of the East/Central/South African CHIKV genotype. A quarter of participants
available for follow-up (16/60, 26.6%) reported being admitted to hospital including two
children with haemorrhage, reflecting the severe phenotype linked to this genotype.
Increased understanding of the health and economic burden of Chikungunya is needed,
and recognition that severe and occasionally fatal infection exists. With widespread pres-
ence of Ae. aegypti and household water storage practices that encourage mosquito breed-
ing, timely actions will be essential to prevent further large outbreaks.
Introduction
Chikungunya is often considered a mild illness and its public health impact underestimated in
Africa and the Middle East despite the fact that greater severity and long-term sequelae have
been reported increasingly in recent years.[1–3]
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First isolated in Tanzania in 1952,[4] Chikungunya virus (CHIKV) was implicated in rural
outbreaks and sporadic cases across Africa until 1980 when it effectively disappeared. In 2004,
however, it reappeared with a vengeance in a pandemic that spread from Kenya to the Indian
Ocean islands and Asia, causing millions of infections.[5,6] In central Africa, sizeable CHIKV
outbreaks in cities signalled a major shift in transmission to urban settings.[2,3,7–9]
Early symptoms of CHIKV are similar to many tropical febrile illnesses but it is differenti-
ated by debilitating arthralgia, often bilaterally and in multiple joints. Other symptoms include
headache, gastrointestinal problems, fatigue, asthenia, peripheral oedema and conjunctivitis.
[10] Although most cases improve after 1–2 weeks, recent outbreaks have seen higher inci-
dences of severe illness, including sepsis and cardiac, renal, neurological, skin and ocular man-
ifestations, and of longer-term effects including persistent pain, rheumatic symptoms,
depression, and mood and sleep disorders.[11–16] A meta-analysis of chronic symptoms stud-
ies in 15 outbreak countries found 43% of cases had not recovered at three months and 21%
were unrecovered at 12 months. Long term neurodevelopmental delays have been reported in
infants symptomatically infected through vertical transmission.[17,18] Treatment for Chikun-
gunya involves supportive care and anti-inflammatory drugs, but as yet there is no antiviral
treatment nor vaccine.[19]
Recent outbreaks have also challenged the view that CHIKV fatality is rare. Case mortality
of 10–48% was reported in the Reunion Island outbreak among cohorts of hospitalised
patients.[13,16] Central nervous system infections with fatal outcomes have been reported in
the Americas.[20] Other locations have documented substantial rises in all-cause deaths dur-
ing outbreak periods.[20–23]
Hypotheses to explain these changes include persistent immune activation triggered by
viral debris, improved surveillance, and genetic mutation, particularly a new variant known as
the Indian Ocean Lineage (IOL) which, since the 2004–2006 pandemic, has been linked to
greater severity and the highest rates of non-recovery.[24] IOL has also been linked to
increased risk of outbreak as some forms contain a mutation that allows CHIKV to use the
temperate-dwelling Aedes albopictus mosquito as a vector as well the tropical Aedes aegypti.
[5,24]
In low-resource settings, outbreaks of undifferentiated febrile illness (UFI) are both com-
mon and a diagnostic challenge. The Federal Republic of Sudan has seen 12 major outbreaks
of UFI since 2012, frequently associated with haemorrhage and high case fatality ratios [25]
and a range of high-consequence infectious diseases are endemic or epidemic in Sudan. Cri-
mean-Congo haemorrhagic fever was recently identified as a common pathogen in a retro-
spective investigation of outbreaks in Darfur.[25] Yellow fever virus epidemics occur [26] and
outbreaks of dengue fever are common.[27] The Federal Ministry of Health (FMoH) main-
tains a sentinel surveillance system and supports individual states with rapid response teams
and enhanced diagnostic capability at the National Public Health Laboratory (NPHL) in
Khartoum.
In late July 2018, the sentinel surveillance in Kassala State (Fig 1) detected an increased fre-
quency of UFI, and CHIKV was identified by the NPHL in the blood sample of a traveller to
Kassala city from nearby Red Sea State. In mid-September reports of cases with more severe
symptoms, including haemorrhage, raised fears that another pathogen might be involved.
Using a pre-prepared, locally and internationally-approved protocol, FMoH and Kassala
Teaching Hospital (KTH), supported by Kassala University and the UK Public Health Rapid
Support Team, deployed a small pre-trained study team of clinical, epidemiology and labora-
tory staff to investigate the outbreak syndrome, confirm the outbreak pathogen, and sequence
the outbreak strain.
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Methods
Ethics statement
Ethical approval was granted by the FMoH Technical Review Board, and Ethics Committees
of Karary University, Khartoum (03 August 2017) and the London School of Hygiene & Tropi-
cal Medicine (Ref: 11930). All participants or parents/guardians of children aged under 18
years provided written informed consent and assent was sought from children aged 12–18.
Participant recruitment
The study was a prospective hospital-based observational cohort of consecutive patients pre-
senting to the Kassala Teaching Hospital medical and paediatrics outpatient departments
between 10th and 16th October 2018. Recruitment criteria were individuals of any age or sex
with symptoms consistent with the KTH case definition for Chikungunya, namely history of
fever or a measured fever of>37.5˚C (tympanic), and at least three of the following clinical
features: headache, anorexia, lethargy, aching muscles or joints, breathing difficulties, vomit-
ing, diarrhoea, stomach pain, difficulty swallowing, and hiccups, or bleeding of any kind.
Patients with a positive malaria RDT were enrolled if they fit the study syndrome in case of co-
infection. Participants were enrolled at presentation and blood samples taken immediately.
Epidemiological information, clinical symptoms at presentation and subsequent laboratory
results were recorded on standardised pro-formas. The follow-up component took place 70–
120 days after enrolment (Jan-Feb 2019) depending on the availability of participants. Adults
who responded to phone follow-up provided convalescent samples and completed the WHO-
validated Routine Assessment of Patient Index Data 3 (RAPID3) disability and pain survey.
Fig 1. Study location: Kassala state, located in Eastern Sudan, 600 km the capital city, Khartoum. covers an area of
42,282 km2 and has a population 1.8 million inhabitants. Kassala City is the State capital with a population of ~
400,000. Kassala Teaching Hospital is the State tertiary hospital and provides service for all patients referred from
health centres and rural hospitals. The source of the map is: https://commons.wikimedia.org/w/index.php?curid=
16093732.
https://doi.org/10.1371/journal.pntd.0009387.g001
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[28] Children were not asked to return due to common reluctance to allow blood-draw from
healthy children, but outcome and duration of hospital stay were confirmed with parents by
phone. All contactable participants were given their RT-PCR test results.
The study protocol (available at https://doi.org/10.17037/DATA.00002018) was based on
the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC)
Clinical Characterization Protocol for Severe Emerging Infections and adapted to context.[29]
The sample size of 140 cases was informed by literature3 and feasible recruitment in the urgent
time frame (7 days).
Laboratory analysis
Haematology (Mindaray 3000 Plus, China), biochemistry analysis (Biosystem BTS 310, Ger-
many), and malaria rapid diagnostic tests (P. falciparum RDT, SD Bioline, USA) were per-
formed on all participants. Plasma samples were frozen at -80˚C and transported under liquid
nitrogen to the NPHL in Khartoum where nucleic acid was extracted (QIAamp Viral RNA
Mini kit, Qiagen, Germany) and RT-PCR performed to detect CHIKV RNA (RealStar Chikun-
gunya RT-PCR Kit 2.0, Altona Diagnostics, Germany) and DENV RNA (RealStar Dengue
RT-PCR Kit 2.0, Altona Diagnostics, Germany) using Rotor Gene Q or Corbett RG6000 ther-
mocyclers. Exposure to CHIKV and DENV was assayed by anti-chikungunya and anti-dengue
IgM and IgG indirect ELISA (Euroimmun, Germany).
Due to limited availability of anti-chikungunya IgM ELISA kits, CHIKV RT-PCR-negative
samples were prioritised for IgM testing, followed by 69 CHIKV RT-PCR-positives in order of
recruitment. All samples were tested for CHIKV IgG. An Ebolavirus RT-PCR (RealStar Ebola-
virus RT-PCR Kit 1.0, Altona Diagnostics, Germany) was performed on seven samples from
patients with haemorrhagic symptoms, collected prior to the study to rule out this pathogen:
all were negative.
Data management
All patient data were entered into encrypted software and analysed with STATA (StataCorp
LLC, USA, V14.2). Descriptive statistics are expressed as medians and Inter-Quartile Range
(IQR) or means and standard deviations (SD) for continuous variables, and frequencies and
proportions for categorical variables. Fisher’s exact, Chi2, T-tests and Spearman’s Rank Order
coefficients were used to assess association and correlation related to CHIKV RT-PCR result.
Significance was set at p<0.05. Only RT-PCR results were used in comparative analyses.
Genetic sequencing
Complementary DNA (cDNA) was prepared and Sequence Independent Single Primer
Amplification (SISPA) performed prior to library preparation using Oxford Nanopore kits
(SQK-LSK108). Sequencing on flow cells (FLO-MIN106) was done using the MinION (Oxford
Nanopore Technologies) as previously described.[30] Thirty samples were sequenced at
NPHL and analysed using Albacore 1.2 to basecall, Mash Screen [31] was used to identify the
most closely matched genome on Genbank, and a reference guided genome assembly con-
structed as described previously.[30] The first seven sequences were used to construct a basic
phylogenetic analysis using MEGA version 6 in order to identify the Kassala strain in Sudan.
With FMoH permission, sample aliquots were also transferred to PHE Porton and sequenced
using the same methods. The resulting viral genetic sequences were sent to Oxford University
Department of Zoology for phylogenetic analysis.
Whole genome sequences were aligned with publicly available complete CHIKV genomes
belonging to the ECSA genotype using MAFFT v7.450 implemented in Geneious R8.[32] A
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maximum likelihood (ML) phylogenetic tree was estimated using RAxML 8.0 [33] under a
GTR substitution model with a Gamma model of among-site rate heterogeneity. The estimated
ML phylogeny was midpoint rooted, and node support was assessed through 100 ML boot-
strap replicates. The geographic location and amino acid identity at site E1-226 of each
sequence were annotated in the tree to explore the phylogenetic distribution of those traits.
Results
Of 155 patients approached over seven days, 102 adults and 40 children were included in the
analysis. Eleven patients or their guardians refused to participate, and two cases whose samples
were lost were excluded. (Fig 2).
Participants were aged 4 months to 70 years (mean 27 years, SD 17.6); 47.9% were female,
none were pregnant (Table 1). Almost half (46.1%, 65/141) were people likely to spend more
time in a household compound (e.g. housewives, unemployed, retired, children under 5).
Median household size was 8. Two-thirds of participants lived in brick/concrete houses with
their own well and sanitation, the remainder lived in less permanent material structures with
shared water and sanitation. A third kept animals in their compound.
Laboratory results
Of 142 participants, 120 were confirmed positive for CHIKV infection by RT-PCR, giving the
case definition used a positive predictive value of 84.5%. CHIKV RT-PCR cycle threshold (Ct)
values ranged from 12–37 (mean 27.3, SD 7.6); over a quarter (27.5%) had a Ct value corre-
sponding with a high viral load (Ct<20) (Table 2). A significant positive correlation existed
between Ct value and both the number of days between onset and recruitment/sampling
(Spearman r = 0.37, p<0.001) and lymphocyte count (r = 0.23, p = 0.012). No other significant
correlations were found. Prolonged viremia was observed in seven CHIKV RT-PCR-positives
Fig 2. Flow diagram of study participants and virological findings: CHIKV: Chikungunya; DENV: Dengue Virus.
ELISA IgM testing was limited by kit availability: CHIKV RT-PCR-negative samples were prioritised, followed 69
CHIKV RT-PCR positive samples in order of recruitment.
https://doi.org/10.1371/journal.pntd.0009387.g002
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who presented 10 days after disease onset. Of 91 participants tested for CHIKV IgM antibod-
ies, 45 were positive including 14 participants who were negative on CHIKV RT-PCR (Fig 2).
There are several possible explanations for the IgM positive but RT-PCR negative cases: an
acute or recent infection outside the viraemic phase of infection and therefore outside the diag-
nostic window for RT-PCR, prior CHIKV infection but unrelated to this outbreak (as IgM
may persist for months [34]) or a false assay result.
Nine CHIKV RT-PCR-positive participants (7.5%) were co-infected with DENV, defined
as being positive on DENV RT-PCR. A further 14 CHIKV RT-PCR-positive participants had
evidence of DENV IgM antibodies, potentially indicating current or recent DENV infection,
or due to cross reactivity of other flavivirus infections. Of all samples (CHIKV-positive and
negative), 81.6% (115/141) were DENV IgG-positive suggesting previous infection with
DENV or cross-reactive flaviviruses. Of the 118 CHIKV RT-PCR-positive participants with a
falciparum malaria RDT result, 28.8% were positive, with the highest proportion in those aged
15–29 years. No participants were co-infected with all three pathogens.
Among the 69 CHIKV RT-PCR-positive participants tested for CHIKV IgM, 31 (44.9%)
were positive. Of the 119 CHIKV RT-PCR tested for CHIKV IgG, 34 (28.6%) were positive
(Fig 2). Of the 22 CHIKV RT-PCR-negative participants, 14 (63.6%) were CHIKV-IgM posi-
tive and 10 (45.5%) were CHIKV IgG positive. Participants who were CHIKV-positive on
both RT-PCR and IgM ELISA presented later in illness course than those who were CHIKV
RT-PCR-positive and IgM-negative (p<0.001). This finding was replicated with CHIKV
Table 1. Participant characteristics by Chikungunya (CHIKV) RT-PCR result.
total CHIKV positive (n = 120) % CHIKV negative (n = 22) %
Sex
Female 47.9% 56 82.3 12 17.7
Male 52.1% 64 86.5 10 13.5
Age (y), median [IQR] 22 14–40 37 21–54
Age Group (y) (n = 141)
<2 7 7 5.9 0 0.0
2–4 6 5 4.2 1 4.5
5–14 24 22 18.5 2 9.1
15–29 51 46 38.7 5 22.7
30–49 33 26 21.8 7 31.8
50+ 20 13 10.9 7 31.8
Occupation (n = 141)
< 5 child 13 12 10.0 1 4.8
Schoolchild/student 49 43 35.8 6 28.6
Housewife 31 26 21.7 5 23.8
Farmer/Outdoor worker 15 12 10.0 3 14.3
Professional/Business 7 7 5.8 0 0.0
Health worker 5 3 2.5 2 9.5
Retired/unemployed 21 17 14.2 4 19.0
Median household size (IQR) n = 102 8 8 6–11 7 5–9
Notes: Missing data: age 1, occupation 1, # in household 40. IQR: Interquartile Range
Most participants who provided residence location (69%, 80/116) came from Kassala City sectors 2, 3, 4 and 5 on the banks of the seasonal River Gash, coinciding with
areas of greatest flooding in the 2018 rainy season, and with highest case reports during the epidemic. A further 26% (30/116) were from rural areas up to 1.5 hours’
drive away.
https://doi.org/10.1371/journal.pntd.0009387.t001
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RT-PCR & IgG-positive patients who presented later than CHIKV IgG-negative patients
(p = 0.002).
Clinical presentation
Median delay from symptom onset to presentation was 2 days (IQR 1–4, n = 139) with no dif-
ference by CHIKV diagnosis or age (Table 2).
Most common symptoms at presentation among CHIKV RT-PCR-positive participants
were current or history of fever (97.5%, 2.5% data unrecorded), headache (88.2%), fatigue
(82.5%), muscle, joint and back pain (66.0%, 83.8%, 50.9% respectively), loss of appetite
(40.4%) and vomiting (40.2%). Patients who were found to be CHIKV RT-PCR-negative had
similar presenting symptoms. Five percent (6/120) of CHIKV RT-PCR-positive participants
reported bleeding, including haematemesis (4), oral bleeding (2), epistaxis (3), petechiae (1),
haemoptysis (1) and melaena (1). None of those with haemorrhagic symptoms were co-
Table 2. Clinical symptoms and cycle threshold (Ct) values of participants at presentation by CHIKV RT-PCR result (n = 142).
CHIKV positive CHIKV negative
Days from onset to presentation (median) 2 IQR 1–4 2 IQR 1–5
Symptoms at presentation % %
Fever/history of fever 117 97.5 22 100.0
Any bleeding 6 5.0 1 4.8
Headache 97 80.8 17 85.0
Joint pain 93 77.5 15 75.0
Fatigue 85 70.8 17 81.0
Muscle pain 66 55.0 16 76.2
Back pain 55 45.8 9 42.9
Loss of appetite 46 38.3 6 28.6
Vomiting 45 37.5 8 38.1
Abdominal pain 32 26.7 8 38.1
Lack of strength 25 20.8 4 100.0
Dizziness 18 15.0 3 14.3
Chest pain 17 14.2 3 15.0
Cough 17 14.2 2 9.5
Rash 13 10.8 2 9.5
Diarrhoea 11 9.2 2 10.0
Dysphagia 9 7.5 3 15.0
Dehydration 9 7.5 1 33.3
Shortness of breath 7 5.8 2 10.0
Conjunctivitis 7 5.8 3 15.0
Sore throat 6 5.0 0 0.0
Confusion 3 2.5 0 0.0
RT-PCR cycle threshold (Ct)
High (Ct <20) 33 27.5 -
Moderate (Ct 20–29) 24 20.0 -
Low (Ct 30–38) 63 52.5 -
Other pathology
Malaria RDT positive 34/118 28.8 5/22 22.7
DENV positive (RT-PCR) 9/120 7.5 3/22 13.6
Notes: RDT Rapid Diagnostic Test. Missing data: fever 3; onset date 3; malaria RDT 2.
https://doi.org/10.1371/journal.pntd.0009387.t002
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infected with DENV but one–a 9-year-old child with haematemesis–was co-infected with
malaria. Eighteen of 78 CHIKV RT-PCR-positive adults (23.1%) were hypotensive (systolic
blood pressure <100 mmHg) and seven (9.0%) were tachycardic (pulse >100), one of whom
was co-infected with DENV. Only one person was both tachycardic and hypotensive.
Information on duration of admission was collected at follow-up. Of the 30 child guardians
and 30 adult participants who responded to follow-up, 16 (26.6%) reported being admitted.
All were CHIKV RT-PCR positive and none were coinfected with DENV, but 60% (7/12 chil-
dren, 2/4 adults) had a positive falciparum malaria RDT. Children were more likely to be
admitted than adults (40.0% vs 13.3%, Fisher’s p = 0.04) and for longer: mean 4.7 days (sd 4.1)
compared to 2.3 days (sd 1.3) for adults. Both adults and children were more likely to be
admitted if they were malaria positive (p = 0.002), and children if they were bleeding
(p = 0.054). One of the four children admitted for seven or more days was malaria positive.
In analysis of blood chemistry, a significant difference was found in mean haematocrit lev-
els between CHIKV RT-PCR-positive (mean 35.9, SD = 6.27) and negative participants (mean
38.9, SD = 7.41, p = 0.05). There were no other significant differences in blood chemistry.
Heart rate and blood pressure were similar in both groups. In the CHIKV RT-PCR-positive
cohort median haematology and biochemistry results were all within normal ranges (Table 3).
Leucopenia (white blood count < 4 x 109/L) was observed in 29% (35/120) and lymphopenia
(< 1 x 109/L) observed in 50.7% (61/120). Elevated AST (>40IU/L) was observed in 22.5%
(27/120) with six participants at levels> 100 IU/L (max 259 IU/L). ALT levels >51 IU/L were
seen in seven participants with four recording levels >100 (max 150 IU/l). Acute kidney injury
was observed in one fatal case. Platelet counts < 100 x 109/L were recorded in 23/120 CHIKV
RT-PCR-positive participants, of whom 14/23 (60.9%) were also falciparum malaria RDT-pos-
itive and none were DENV PCR-positive. Platelet counts < 50 x 109/L were observed in six
participants, three of whom also had positive malaria RDT.
Compared to those with a single infection, CHIKV/DENV co-infected participants had
higher mean systolic blood pressure (p = 0.03) haemoglobin (p = 0.01), haematocrit (p = 0.03),
Table 3. Mean clinical parameters of participants at presentation by CHIKV RT-PCR result.
CHIKV positive SD n CHIKV negative SD n
Heart rate (beats/min) 91.2 19.2 114 83.5 15.8 21
Respiratory rate 20.4 2.9 12 18.0 n/a 1
Systolic pressure 102.9 20.2 78 106.3 12.5 20
Diastolic pressure 68.0 13.1 78 70.2 7.5 20
Haemoglobin (g/dL) 11.6 2.2 120 12.5 2.5 22
Haematocrit (%)� 35.9 6.3 119 38.9 7.4 22
WBC (103/uL) 6.1 3.1 120 4.8 2.2 22
Lymphocytes (103/uL) 2.1 2.4 118 2.9 6.6 22
Platelets (109/L) 227.0 143.3 120 190.6 131.0 22
Nitrogen oxide 3.8 2.0 113 2.9 1.7 22
Urea (mg/dL) 24.8 14.9 119 26.1 11.3 22
Creatinine (mg/dL) 0.8 0.7 119 0.9 0.2 22
Bilirubin 0.7 1.5 119 0.9 1.3 22
AST (IU/L) 36.0 33.9 119 28.2 17.4 22
ALT (IU/L) 23.1 23.4 118 21.5 14.4 22
Albumin 14.9 6.8 69 17.6 6.4 17
Notes: WBC White Blood Cells; AST Aspartate aminotransferase; ALT Alanine aminotransferase.
�Significant difference p = 0.049
https://doi.org/10.1371/journal.pntd.0009387.t003
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bilirubin (p = 0.002) and albumin (p =<0.001). They were also more likely to present with
back pain than those with CHIKV alone (p = 0.003).
Severe or fatal disease
The study recruited one case with a fatal outcome–a male teacher aged 52 transferred to KTH
13 days after onset of symptoms. He was CHIKV RT-PCR-positive with a Ct of 30 and no
coinfection. At admission he had petechiae and minor bruising but no other evidence of bleed-
ing. He died from sepsis complicated by disseminated intravascular coagulation and acute kid-
ney injury (Blood/Urea/Nitrogen (BUN) 154 mg/dL, creatinine 7.8 mg/dL, AST 259 IU/L,
ALT 59 IU/L, platelets 111 x 109/L).
Two children in extremis with significant haemorrhage were recruited at the paediatric
department. Both were CHIKV RT-PCR-positive without coinfection. The 16-year-old was
admitted on day 2 of illness with a history of fatigue, headache, back pain, anorexia, oral muco-
sal haemorrhage, and profuse epistaxis. He was in shock (pulse 120, BP 84/50, respiratory rate
25) with a platelet count of 10 x 109/L, Hb 12.5 g/dL, WBC 10.5 x 103/uL, HCT 38.9%, AST 47
IU/L, ALT 24 IU/L, BUN 26 mg/dL, creatinine 0.8 mg/dL and CHIKV RT-PCR Ct 29.63. He
was resuscitated with blood and platelet transfusion, underwent nasal packing, and was dis-
charged after 15 days. The second child aged 7 years presented on day 0 of illness with epi-
staxis, haematemesis, melaena, bruising and anorexia. Her pulse was 130 and Hb 10.2 g/dL,
WBC 4.6 x 103/uL, platelet count 20 x 109/L, HCT 30.7%, urea 22 mg/dL, creatinine 0.5 mg/
dL, AST 175 IU/L, ALT 129 IU/L and CHIKV RT-PCR Ct of 26.8. She was also resuscitated
with blood and platelets and discharged well after nine days’ admission.
Factors associated with CHIKV positivity
The mean age of CHIKV RT-PCR-positive patients was significantly less than CHIKV
RT-PCR-negative patients (p = 0.003). CHIKV RT-PCR-positives were also more likely to
report having been in contact with someone who was ill (p = 0.01) but as CHIKV is not trans-
mitted person-to-person, this finding likely relates to being in the same vector environment.
No associations were found with any other exposure including mass gatherings, funerals/
corpses, or contact with livestock, birds or rodents.
Convalescent follow-up
Thirty (29.7%) of the 102 adult participants were available for follow-up, 29 (28.7%) refused,
and 42 (41.6%) could not be reached. Median time to follow-up for adults was 75 days (IQR
71–94) after enrolment; 52% were male. Parents of 30 of the 40 child participants responded to
contact. All 60 participants followed-up were CHIKV RT-PCR-positive at baseline. Of adults
followed-up 43.3% (13/30) had spent 1–2 weeks off work and 20.0% (6/30) 2 or more weeks
(Table 4). Twenty-three of the 30 adult convalescent samples collected (76.7%) were IgG posi-
tive: 10 were IgG-positive in both acute and convalescent samples, 13 had seroconverted since
recruitment, and seven remained IgG negative. Children were not sampled.
Chronic disability
Only adult follow-up participants were surveyed for ongoing disability; median age was 27
years (IQR 24–45). Of these, 63.3% (19/30) were still experiencing arthralgia, most frequently
in the knee (46.7% 14/30), ankle (36.7% 11/30) wrist (30.0% 9/30) and shoulder (26.7% 8/30).
Asked to rank pain and general wellbeing over the previous week on a scale where 10 was the
most pain/most unwell, respondents reported a median pain score of 4 (IQR 2–5) and median
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wellbeing score of 7 (IQR 3–8) (Table 4). A third (36.6%, 11/30) indicated their pain was
greater or the same as during the acute phase of their illness, and even those with less pain
than before reported continuing to take painkillers, anti-inflammatories, corticosteroids, or all
three, for their condition. In total, 60% continued to take medication.
Of the 28 respondents who completed the RAPID3 disability survey, three-quarters
reported a continuing effect on day-to-day activities, including difficulties getting out of bed
(28%), walking 2 miles (35%), and getting in and out of a vehicle (17%), while 10–15%
reported difficulty with activities such as turning on taps, bending and sleeping well. Rapid3
scaling indicated that, 70–120 days after their acute illness, 10.7% (3/28) of respondents were
experiencing moderately severe disability and 60.7% (17/28) low severity disability. The
remaining eight (28.6%) respondents were considered nearly recovered (Table 4). Neither age,
sex, level of viremia on admission, or pre-existing conditions such as diabetes, hypertension
and osteoarthritis, were associated with level of residual disability, or duration of absence from
work.
Genetic analysis
Virus genome sequencing found that all CHIKV RT-PCR-positive samples belonged to a sin-
gle monophyletic cluster in the Indian Ocean Lineage (IOL) of the ECSA genotype of CHIKV.
(Fig 3) Between 84–95% (mean 93%) genome coverage was achieved at least x20 depth across
Table 4. Impact of CHIKV infection on work and disability 70–120 days after acute infection.
Adults (n = 101) %/IQR Children (n = 40) %/IQR p (Fisher)
Follow-up response rate 30 29.7% 30 75.0%
Median days to follow-up 75 IQR 71–94 - -
Hospital care (n = 30)
Discharged the same day 26 86.7% 18 60.0% p = 0.039
Admitted for at least 1 day 4 13.3% 12 40.0%
Median days admitted 2 IQR 1.5–3 3 IQR 2–7
Absence from work
< 1 week 11 36.7%
1–2 weeks 13 43.3%
3–4 weeks 4 13.3%
>4 weeks 2 6.7%
RAPID3 disability score (n = 28)
Near remission 8 28.6%
Low disability 17 60.7%
Moderate disability 3 10.7%
Current presence of pain (n = 30) 19 63.3%






Median pain perception score 4 IQR 2–5
Median wellbeing score 7 IQR 3–8
Notes: Pain perception and wellbeing are scored on a 0–10 scale with 10 being the worst pain and feeling the worst. IQR: Inter Quartile Range
https://doi.org/10.1371/journal.pntd.0009387.t004
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all samples (Genbank Accession Nos. MW161364-161460). This clade is distinct from those
previously identified in Western and Central Africa, suggesting that the Kassala outbreak
was caused by an independent introduction of an IOL strain into the region. This might have
occurred via the Middle East or Indian Subcontinent since the Kassala sequences are closely
related (i) to the Henan and Shivane variants identified in China and Hong Kong, which
originated in returning travellers from India/Pakistan, and (ii) to a clade that includes
sequences from a 2016 outbreak in Pakistan and other sequences from India and Bangladesh.
Absence of the A226V mutation—a mutation associated with the capacity of the virus to
infect Ae. Albopictus [35,36]—confirms Ae. aegypti as the most likely outbreak vector spe-
cies.(S1 Text)
Fig 3. Maximum likelihood phylogenetic tree of the ECSA genotype and its two distinct lineages showing the location of the Kassala 2018/19 strain: Maximum
likelihood phylogenetic tree of the East/Central/South African (ECSA) genotype and its two distinct lineages: the Indian Ocean Lineage (IOL) and the Middle African/
South American (MASA) lineage. The monophyletic Kassala epidemic clade groups with sequences that originate from the Middle East and India and represents a
distinct lineage from other African CHIKV variants. Node support values were evaluated using 100 bootstrap replicates and are illustrated using colour at nodes (with
white representing 0 and black representing 100). The 2016 Mandera outbreak also represents a possible introduction from the Indian subcontinent and appears to be an
independent event from the Kassala epidemic. Neither the Mandera or Kassala outbreak contained the A226V albopictus adaptive variant.
https://doi.org/10.1371/journal.pntd.0009387.g003
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Discussion
Our phylogenetic analysis suggests the unprecedented Chikungunya epidemic that took place
in the Eastern states of Sudan in 2018–19 was caused by an independent introduction of a
CHIKV IOL virus, of the same lineage responsible for the outbreaks observed worldwide dur-
ing 2004–2007 and linked to more severe manifestations of CHIKV disease.[24]
Over the nine months of the epidemic, Kassala State and Red Sea State reported 48,763
cases of chikungunya. Seroprevalence surveys in other outbreak locations, however, suggest
only 2–15% of cases are captured by surveillance and reporting systems.[37–40] A conservative
estimate of 10% of cases captured suggests some 487,600 cases occurred in the Kassala and Red
Sea State epidemic, making it the largest outbreak of Chikungunya in Africa and the Middle
East to date. There are multiple reasons to suspect substantial under-reporting and under-
diagnosis in this outbreak including: use of a sentinel surveillance system normally intended to
raise an alert rather than capture every case (one study reported a ratio of 67 symptomatic
cases for every one picked up by the sentinel system [40]), population reluctance to seek medi-
cal attention at hospitals due to cost and limited treatment options, limited diagnostic
resources, absence of data collection in private clinics, and the range of CHIKV illness severity.
Made possible by the established research collaboration between the FMoH and the UK Public
Health Rapid Support Team on outbreak response, this study utilised pre-approved protocols, pre-
trained staff and, for the first time within Sudan, next generation sequencing technology in-coun-
try. We confirmed that CHIKV was the dominant pathogen responsible for the outbreak, that
DENV was also circulating with 1 in 5 CHIKV positive patients co-infected and, importantly, that
there was a high frequency of falciparum malaria transmission and of CHIKV/malaria co-infec-
tion. The 14 cases with chikungunya RT-PCR negative and ELISA IgM positive results were not
unexpected given that the diagnostic window for IgM and RT-PCR are different (IgM antibodies
emerge later during the infection and last for longer [34] than the viraemic phase when RNA is
identified by RT-PCR). Other possible explanations are prior CHIKV infection but unrelated to
this outbreak (as IgM may persist for months [34]) or a false assay result. As IgM/IgG results can-
not confirm a diagnosis they were not used to define Chikungunya infection in any analyses.
The cohort recruited were young (median age 27) and largely presented with non-specific
febrile symptoms plus poly-articular joint pain. Nevertheless, based on our follow-up cohort, a
substantial proportion—one in four—were admitted to hospital, reflecting the impact of the
high frequency of malaria co-infection (60%) as well as the severe phenotype observed in a
subset of patients, including the potential for haemodynamic disturbance in adults. As we have
described, 5% of patients with CHIKV (P. falciparum and DENV negative) had evidence of
bleeding and loss of haemostasis. Two children in particular were gravely unwell with life-
threatening haemorrhage associated with severe thrombocytopenia and need for blood prod-
uct resuscitation, while one adult died of multi-organ failure including acute kidney injury.
Severe and fatal CHIKV infection has been reported previously during outbreaks challeng-
ing the misconception that it is only a mild self-limiting diseases.[13,41] Increased risk of
severe disease has been suggested in extremes of age (neonates and > 65 years) and those with
underlying medical problems including immunosuppression.[10,15] Severe disease has been
associated with neurological complications such as acute flaccid paralysis and Guillain-Barré
syndrome.[42–44] Brazil, Reunion Island and India all reported higher case fatality and excess
deaths during their epidemics, [12,13,16,21,22] though fatality is still considered rare, occur-
ring in less than 1 in 1000 cases.
Although we did not find associations between severe illness and age in our study, or with
chronic illness, due to our age-limited follow-up, the findings described by previous studies
are consistent with the severe phenotype of CHIKV we observed in Kassala, including a one
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confirmed CHIKV RT-PCR-positive death and life-threatening bleeding due to loss of hae-
mostasis with thrombocytopenia. The high frequency of P. falciparum infection detected
underpins the importance of both malaria diagnostics and public messaging in malaria-
endemic settings when chikungunya outbreaks occur.
Our study was biased towards more severe cases due to hospital-based recruitment and had
a low response rate in follow-up where we also lacked a control group. There was a low
reported sensitivity of 76.7% (23/30) for the CHIKV IgG ELISA in the convalescent samples
tested but it was not possible to determine whether this was due to assay failures or other fac-
tors, in part, due to the inability to retest original acute samples to verify results.
However, our findings that 63% of respondents had persistent pain three to four months
after acute illness are similar to those of a case-controlled study on La Reunion Island. This
study found 53% of IOL-strain CHIKV-positive participants reported twice as much pain
compared to controls 12 months after their illness.[45] Our findings were also similar to those
of a meta-analysis of chronic disability across all CHIKV strains which found on average 52%
of IOL-strain patients were still disturbed by symptoms at three months, compared to 39% of
Asian lineage and 14% of ECSA group patients.[24]
Our finding that the only significant risk factor for contracting CHIKV was proximity to a
case suggests identifying and supporting vector control measures acceptable to the community
should be a priority for public health authorities seeking to prevent future CHIKV and other
Aedes-transmitted epidemics in Sudan. Entomological research carried out by Kassala Univer-
sity in 2014/15 showed high Ae. aegypti density across the city and a high proportion of house-
holds storing water in their compounds in un-protected clay pots.[46–48] In 2018 the
situation was exacerbated by intense seasonal rainfall which displaced 50,000 residents and
flooded many areas, a situation repeated in 2020.
Measures such as improved water infrastructure, covered water storage containers, and
increased population awareness of the importance of preventing mosquitoes from breeding in
household compounds are important.[46] Heightened vector surveillance is also needed to
monitor for presence of Ae. albopictus, which could prompt further outbreaks of different
CHIKV strains, and to investigate the potential role in the sylvatic cycle of the large population
of Macaques monkeys which live close to residential areas.
Finally, but importantly, it is essential that State Ministries of Health throughout Sudan
enhance their risk communication and public information strategies around Chikungunya to
underline that severe and occasionally fatal infection exists. With widespread presence of Ae.
aegypti and a similar water storage practices throughout Sudan, timely official and community
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42. Sá PKdO, Nunes MM, Leite I, Campelo M, Leão C, Souza JdC, et al. Chikungunya virus infection with
severe neurologic manifestations: report of four fatal cases. Revista da Sociedade Brasileira de Medi-
cina Tropical. 2017; 50:265–8. https://doi.org/10.1590/0037-8682-0375-2016 PMID: 28562768
43. Wielanek AC, Monredon JD, Amrani ME, Roger JC, Serveaux JP. Guillain-barré syndrome complicat-
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